4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-001868
Chief Financial Officer sold 50,000 shares at an average $10.35 ($517,508)
- Chief Financial Officer acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Secora Michael · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 993,514 | D |
| 2024-01-16 | Sale : show line 2 in the form 10b5-1 | −25,000 | $10.45 | $261,160 | 968,514 | D |
| 2024-01-17 | Exercise or conversion : show line 3 in the form 10b5-1 | +37,500 | $2.22 | $83,250 | 1,006,014 | D |
| 2024-01-17 | Sale : show line 4 in the form 10b5-1 | −25,000 | $10.25 | $256,348 | 981,014 | D |
| Open-market sales · 50,000 sh · avg $10.35 · $517,508 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,072,635 | D |
| 2024-01-17 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −37,500 | $2.22 | 2030-03-03 | 37,500 | 1,035,135 | D |
Loading xslF345X05/doc4.xml…